Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free

- CML community recognizes September 22 as World CML Day to raise awareness of the needs of patients living with CML

- Novartis commemorates World CML Day, announcing 100+ study sites across 40 countries now enrolling patients to its global treatment-free remission clinical trials

- Treatment-free remission program evaluates whether patients can maintain undetectable levels of disease after stopping therapy

Sep 19, 2013, 07:15 ET from Novartis